Christian Voigtlander - Mar 6, 2023 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Chief Operating Officer
Signature
By: Paula Darbyshire, Attorney-in-fact For: Christian B. Voigtlander
Stock symbol
ICUI
Transactions as of
Mar 6, 2023
Transactions value $
-$1,233,384
Form type
4
Date filed
3/8/2023, 03:59 PM
Previous filing
Mar 8, 2022
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +8.75K +64.71% $0.00 22.3K Mar 6, 2023 Direct
transaction ICUI Common Stock Tax liability -$742K -4.6K -20.68% $161.25 17.7K Mar 6, 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +1.55K +8.78% $0.00 19.2K Mar 6, 2023 Direct F1
transaction ICUI Common Stock Tax liability -$132K -816 -4.25% $161.25 18.4K Mar 6, 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +2.15K +11.66% $0.00 20.5K Mar 7, 2023 Direct F1
transaction ICUI Common Stock Tax liability -$178K -1.13K -5.5% $157.47 19.4K Mar 7, 2023 Direct
transaction ICUI Common Stock Options Exercise $0 +2.21K +11.38% $0.00 21.6K Mar 8, 2023 Direct F1
transaction ICUI Common Stock Tax liability -$182K -1.16K -5.38% $156.17 20.5K Mar 8, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 -1.55K -100% $0.00* 0 Mar 6, 2023 Common Stock 1.55K $0.00 Direct F1, F2, F3
transaction ICUI Common Stock Options Exercise $0 -2.21K -49.99% $0.00 2.21K Mar 8, 2023 Common Stock 2.21K $0.00 Direct F1, F2, F3, F4
transaction ICUI Common Stock Options Exercise $0 -2.15K -33.33% $0.00 4.29K Mar 7, 2023 Common Stock 2.15K $0.00 Direct F1, F2, F3, F4
transaction ICUI Performance Shares Options Exercise $0 -8.75K -100% $0.00* 0 Mar 6, 2023 Common Stock 8.75K $0.00 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are Restricted Stock Units.
F2 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F3 These are restricted stock units that fully vest 3 years from the grant date.
F4 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5 These Securities are Performance-based Restricted Stock Units (PRSU).
F6 There is neither a purchase price nor an exercise price for the PRSUs.
F7 These PRSUs were granted on March 6, 2020 and were subject to the satisfaction of both performance-based and time-based criteria. These PRSUs had a 3-year performance period and cliff-vested on the third anniversary of the grant date.